| DOW + 1.02% | NASDAQ + .31% | S&P +.06%
Past Winners
The Stock Poised to Rewrite the Biotech Playbook
When we first spotlighted Quantum BioPharma Ltd. (NASDAQ: QNTM) in October 2024, the company was trading quietly in the high $3s, steadily building a foundation that few outside biotech circles fully appreciated. Since then, the stock has ignited a parabolic rally that’s turning heads across Wall Street — surging well beyond the initial alert levels and signaling that something extraordinary is underway.
Past Winners
The Stock Poised to Rewrite the Biotech Playbook
When we first spotlighted Quantum BioPharma Ltd. (NASDAQ: QNTM) in October 2024, the company was trading quietly in the high $3s, steadily building a foundation that few outside biotech circles fully appreciated. Since then, the stock has ignited a parabolic rally that’s turning heads across Wall Street — surging well beyond the initial alert levels and signaling that something extraordinary is underway.
Past Winners
PIONEEERING THE TRILLION DOLLAR GREEN CONSTRUCTION REVOLUTION WITH GRAPHENE
The global construction industry faces mounting pressure to address aging infrastructure, rising costs, and environmental mandates. Argo Living Soils (OTC: ARLSF, CSE: ARGO) is poised to transform this landscape by integrating graphene—a revolutionary nanomaterial—into concrete and asphalt. With a market cap of CAD $14.47 million as of June 13, 2025, Argo is a small-cap player with outsized potential to disrupt a trillion-dollar market. Its partnership with Graphene Leaders Canada (May 2025) and recent leadership changes signals a clear path toward commercialization.
Past Winners
PIONEEERING THE TRILLION DOLLAR GREEN CONSTRUCTION REVOLUTION WITH GRAPHENE
The global construction industry faces mounting pressure to address aging infrastructure, rising costs, and environmental mandates. Argo Living Soils (OTC: ARLSF, CSE: ARGO) is poised to transform this landscape by integrating graphene—a revolutionary nanomaterial—into concrete and asphalt. With a market cap of CAD $14.47 million as of June 13, 2025, Argo is a small-cap player with outsized potential to disrupt a trillion-dollar market. Its partnership with Graphene Leaders Canada (May 2025) and recent leadership changes signals a clear path toward commercialization.
Copyright Small Cap Exclusive 2025